Severe diarrhea (more than 6 episodes daily, blood in stool, inability to stay hydrated) warrants medical evaluation, but the solution may be a dose reduction or extended hold at the current dose rather than complete discontinuation
Researchers at Washington University School of Medicine have increasingly studied whether GLP-1 medications, originally developed for diabetes and later approved for obesity, could also help treat substance use disorders
By doing so, these injectables assist in weight loss by reducing cravings and promoting a feeling of fullness after eating smaller portions
This triple mechanism, explained thoroughly in the GLP-3 (triple agonist) peptide guide , explains why retatrutide produced weight reduction of up to 24.2% at 48 weeks in phase 2 trials, numbers that exceeded both semaglutide and tirzepatide weight loss outcomes at similar timepoints
Retrieved from Mutuyemungu, E., Singh, M., Liu, S., et al
Improved Exercise Performance: Reduces muscle soreness and fatigue after physical exertion